Evaluating the Test-Retest Reliability and Measurement Error of a Sit-Stand-Power Test in Individuals Treated for Cancer [0.03%]
癌症患者的坐立测试重测信度和测量误差评价研究
Genevieve L Bottone,Kenneth S Anderson,Alexander M Brooks et al.
Genevieve L Bottone et al.
Introduction: Muscular strength and physical function are commonly assessed in exercise oncology trials, yet muscular power is often overlooked despite being an important determinant of morbidity and mortality. The sit-to...
Response to the Letter to the Editor Regarding "Efficacy of Herbal Medicine Therapy Combined with Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis" [0.03%]
客觀評論來信:關於「不可手術晚期肺癌患者使用中成藥聯合減症化療的系統評價和 meta分析」
Dong-Hyeon Kim,Keon-Jun Lee,So-Jung Park
Dong-Hyeon Kim
The Experience of Shared Meditation Involving People With Cancer, Health Professionals and Third Persons: A Qualitative Focus-Group Study [0.03%]
一项关于涉及癌症患者、医务人员和第三方的冥想体验的质性焦点小组研究
Virginie Prevost,Titi Tran,Bénédicte Clarisse et al.
Virginie Prevost et al.
In recent years, mindfulness-based interventions have gained in popularity as a non-pharmacological intervention for improving well-being in oncology. Our project aims to address the benefit of shared meditation involving patients, medical ...
Chinese Herbal Medicine Is Associated With Improved Survival in Patients With Advanced Lung Cancer Receiving Standard Treatment: A Nationwide Population-Based Propensity Score Matching Study [0.03%]
基于国家人口的倾向性匹配研究:中药联合标准化疗可改善晚期肺癌患者预后
Kai-Yuan Hsiao,Wei-Shan Chang,Shi-Chen Ou et al.
Kai-Yuan Hsiao et al.
Purpose: There is a lack of large-scale evidence regarding the prognostic impact of Chinese herbal medicine (CHM) on patients with lung cancer. This paper aimed to conduct a nationwide population-based study to investigat...
Response to Letter to the Editor: Comment on "The Efficacy and Safety of Nutritional Supplements for Cancer Supportive Care: An Umbrella Review and Hierarchical Evidence Synthesis" [0.03%]
来信回复:“癌症姑息治疗的营养补充剂的有效性和安全性:伞式评论和分层证据综合”的评述
Sarah Benna-Doyle,Suzanne Jane Grant,Carolyn Ee
Sarah Benna-Doyle
Biobran/MGN-3, Arabinoxylan Rice Bran, Ameliorates the Liver Architecture in Ehrlich Ascites Tumor-Bearing Mice as a Cotreatment with Chemotherapy [0.03%]
生物制剂/ MGN-3(阿拉比可糖链)稻麸可通过化疗辅助治疗改善ehrlich腹水肿瘤小鼠的肝脏结构
Mai Alaa El-Dein,Doaa A Ali,Mamdooh H Ghoneum
Mai Alaa El-Dein
Background: Hepatic metastases are a leading cause of mortality in gastrointestinal cancers, often exacerbated by the limited efficacy of conventional chemotherapeutics. Biobran/MGN-3, a rice bran-derived arabinoxylan, ha...
A Novel Approach of Intraneural Facilitation Versus Standard Physical Therapy for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial [0.03%]
化疗诱导的外周神经病预防中 intraneural 促进与标准物理治疗的随机对照试验的新方法:一种新型的intraneural促通法与传统的物理疗法在外周神经毒性症状发生后预防癌症化疗导致的手足麻木中的疗效比较:一项随机对照试验
Jamie Hankins,Mark Bussell,Lida Gharibvand et al.
Jamie Hankins et al.
This study compared Intraneural Facilitation (INF®) therapy and standard physical therapy (PT) in preventing chemotherapy-induced peripheral neuropathy (CIPN) in women with newly diagnosed breast and gynecologic cancer. Thirty-eight women ...
Randomized Controlled Trial
Integrative cancer therapies. 2026 Jan-Dec:25:15347354251413222. DOI:10.1177/15347354251413222 2026
Development of an Assessment Tool for YouTube Videos With Medical Content: A Focus on Nutrition and Cancer [0.03%]
一种评估工具的开发:针对YouTube上包含医学内容的视频的营养与癌症主题聚焦研究
Alina Grumt,Sophia Huchel,Christian Keinki et al.
Alina Grumt et al.
Background: Cancer patients increasingly use YouTube for nutritional guidance, yet information quality varies substantially. Existing text-based assessment tools fail to capture audiovisual content characteristics. This s...
Qu-Shi-Jie-Du Decoction for Prevention of Recurrence and Metastasis in High-Risk Stage II/III Colon Cancer: Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Trial [0.03%]
岐黄软肝散预防高危II/III期结肠癌术后复发和转移的临床研究方案:一项随机、双盲、安慰剂对照试验
Ya-Dong Chen,Zi-Yan He,Wen-Jie Zhao et al.
Ya-Dong Chen et al.
Background: Colorectal cancer is one of the most common and fatal cancers worldwide. Despite therapeutic advancements, patients with stage II and III colon cancer often experience recurrences and metastases, particularly ...